scholarly journals Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass

Diabetes Care ◽  
2016 ◽  
Vol 39 (12) ◽  
pp. 2247-2253 ◽  
Author(s):  
Deanna J.M. Isaman ◽  
Amy E. Rothberg ◽  
William H. Herman
Keyword(s):  
Type 2 Diabetes ◽  
Gastric Bypass ◽  
Diabetes Remission ◽  
Remission Rates ◽  
Type 2 Diabetes Remission

Factors Mediating Durability of Type 2 Diabetes Remission and Relapse after Gastric Bypass Operation

2019 ◽  
Vol 229 (4) ◽  
pp. e2
Author(s):  
Bernardo M. Pessoa ◽  
Matthew G. Browning ◽  
Jad Khoraki ◽  
Guilherme Mazzini ◽  
Luke Wolfe ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Gastric Bypass ◽  
Diabetes Remission ◽  
Bypass Operation ◽  
Gastric Bypass Operation ◽  
Type 2 Diabetes Remission

OR48: Metabolomic Study Suggest Preserved Kidney Function as Requirement for Type 2 Diabetes Remission After Roux Eny Gastric Bypass

2019 ◽  
Vol 38 ◽  
pp. S23
Author(s):  
N. Mendonça Machado ◽  
R.S. Torrinhas ◽  
P. Sala ◽  
C. de Siqueira Cardinelli ◽  
G. Ravacci ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Gastric Bypass ◽  
Kidney Function ◽  
Diabetes Remission ◽  
Type 2 Diabetes Remission ◽  
Metabolomic Study

scholarly journals New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”

2020 ◽  
Vol 9 (4) ◽  
pp. 1070
Author(s):  
Ana de Hollanda ◽  
Albert Lecube ◽  
Miguel Angel Rubio ◽  
Enric Sánchez ◽  
Núria Vilarrasa ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Diabetes Remission ◽  
Dynamic Responses ◽  
Type 2 Diabetes Remission

Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to evaluate the “time-within-remission range” as a variable of metabolic control. A descriptive cohort study was done using a computerised multicentre and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects with a follow-up of 4.5 ± 2.5 years were included. Type of surgery, diabetes remission, recurrence of diabetes, “time-within-remission range” and key predictors of diabetes outcomes were assessed. All patients (70% women, 51.4 ± 9.2 years old, body mass index (BMI) 46.3 ± 6.9 kg/m2) underwent primary bariatric procedures. “Time-within-remission range” were 83.3% (33.3–91.6) after gastric bypass, 68.7% (7.1–87.5) after sleeve gastrectomy and 90% (83.3–92.8) after malabsorptive techniques (p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly negatively correlated with the “time-within-remission range”. The association of bariatric techniques with “time-within-remission range”, using gastric bypass as a reference, were: odds ratio (OR) 3.70 (2.34–5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40–0.75), p < 0.001 for sleeve gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric surgery. The “time-within-remission range” unveils a superiority of gastric bypass compared to sleeve gastrectomy.

scholarly journals Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

2014 ◽  
Vol 25 (7) ◽  
pp. 1128-1132 ◽  
Author(s):  
Aurélie Cotillard ◽  
Christine Poitou ◽  
Guillemette Duchâteau-Nguyen ◽  
Judith Aron-Wisnewsky ◽  
Jean-Luc Bouillot ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Gastric Bypass ◽  
Diabetes Remission ◽  
Prediction Tool ◽  
Type 2 Diabetes Remission
Sign in / Sign up

Export Citation Format

Share Document